CLINICAL_TRIALS
trial_result
· 2014-08-13
Clinical Trial Update: OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD [Phase 2, Phase 3]
Summary
Completed Phase 2/3 trial update evaluating OROS methylphenidate (Concerta) for adult attention deficit hyperactivity disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: COMPLETED